Eli Lilly
Trade Eli Lilly 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About LLY
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies.
LLY Key Statistics
Stock Snapshot
With a market cap of 1.31T, Eli Lilly(LLY) trades at $1,390.99. The stock has a price-to-earnings ratio of 43.78 and currently yields dividends of 0.52%.
During the trading session on 2026-10-29, Eli Lilly(LLY) shares reached a daily high of $1,408.38 and a low of $1,320.00. At a current price of $1,390.99, the stock is +5.4% higher than the low and still -1.2% under the high.
Trading activity shows a volume of 1.13M, compared to an average daily volume of 2.39M.
The stock's 52-week range extends from a low of $809.63 to a high of $1,408.38.
The stock's 52-week range extends from a low of $809.63 to a high of $1,408.38.
LLY News
...
Eli Lilly’s quarterly revenue jumped on growing demand for its diabetes and obesity drugs. Mike Blake / Reuters Eli Lilly’s LLY 0.50 %increase; up pointing tri...
Eli Lilly had yet another record quarter as sales of its weight-loss injection Zepbound soared. The company also raised its outlook for the third time this yea...
Analyst ratings
85%
of 33 ratingsMore LLY News
Eli Lilly is slated to report third-quarter earnings and revenue on Thursday, which will likely be fueled by its blockbuster obesity drug Zepbound and diabetes...
Eli Lilly and Co. (NYSE:LLY) shares are trending on Wednesday night. Shares of the Indiana-based pharmaceutical company gained 1.89% to $1,312.68 in after-hour...
Pharmaceutical giant Eli Lilly (LLY) has announced that Patrik Jonsson, executive vice president and president of the company’s international business, will re...
Pharmaceutical giants Merck (MRK) and Eli Lilly (LLY) are scheduled to report third-quarter results on October 29, with analysts expecting a year-on-year earnin...
Technology Eli Lilly's Next-Gen Obesity Drug Trounces Ozempic In Head-To-Head Test Licensing Eli Lilly's (LLY) next-generation weight-loss drug, retatrutide, tr...
Eli Lilly’s (LLY Quick QuoteLLY - Free Report) portfolio is overwhelmingly driven by its popular GLP-1 medicines, Mounjaro and Zepbound. However, Neurosci...
Eli Lilly and Company (NYSE: LLY) said its investigational drug retatrutide delivered "more than double the weight loss of the highest approved dose of Ozempic,...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.